17537235

Source:http://linkedlifedata.com/resource/pubmed/id/17537235

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0016360, umls-concept:C0023413, umls-concept:C0030705, umls-concept:C0036525, umls-concept:C0069717, umls-concept:C0205195, umls-concept:C0282460, umls-concept:C0796392, umls-concept:C1522484, umls-concept:C1527249
pubmed:dateCreated	2007-6-22
pubmed:abstractText	To evaluate the efficacy and the toxicity of front line FOLFOX4 combined with bevacizumab in patients with metastatsic CRC (mCRC).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-10655437, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-10744089, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-11886010, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-12506171, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-12568441, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-14657227, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15051767, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15175435, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15285815, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15309516, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15655642, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15738537, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15761078, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15867200, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-15908660, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-16301832, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-16849748, http://linkedlifedata.com/resource/pubmed/commentcorrection/17537235-17442997
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100967800
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Leucovorin, http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status	MEDLINE
pubmed:issn	1471-2407
pubmed:author	pubmed-author:AgelakiSofiaS, pubmed-author:AndroulakisNikolaosN, pubmed-author:ChatzidakisAdamA, pubmed-author:ChristophylakisCharalambosC, pubmed-author:DiamandidouEleniE, pubmed-author:EmmanouilidesChristosC, pubmed-author:GeorgouliasVassilisV, pubmed-author:KalbakisKostasK, pubmed-author:KalykakiAntoniaA, pubmed-author:KotsakisAthanasiosA, pubmed-author:MavroudisDimitrisD, pubmed-author:SfakiotakiGeorgiaG, pubmed-author:SouglakosJohnJ, pubmed-author:TouroutoglouNikolaosN, pubmed-author:VamvakasLambrosL
pubmed:issnType	Electronic
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	91
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:17537235-Adolescent, pubmed-meshheading:17537235-Adult, pubmed-meshheading:17537235-Aged, pubmed-meshheading:17537235-Antibodies, Monoclonal, pubmed-meshheading:17537235-Antibodies, Monoclonal, Humanized, pubmed-meshheading:17537235-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17537235-Carcinoma, pubmed-meshheading:17537235-Colorectal Neoplasms, pubmed-meshheading:17537235-Female, pubmed-meshheading:17537235-Fluorouracil, pubmed-meshheading:17537235-Humans, pubmed-meshheading:17537235-Leucovorin, pubmed-meshheading:17537235-Liver Neoplasms, pubmed-meshheading:17537235-Lung Neoplasms, pubmed-meshheading:17537235-Male, pubmed-meshheading:17537235-Middle Aged, pubmed-meshheading:17537235-Neoadjuvant Therapy, pubmed-meshheading:17537235-Organoplatinum Compounds, pubmed-meshheading:17537235-Patient Compliance, pubmed-meshheading:17537235-Treatment Outcome
pubmed:year	2007
pubmed:articleTitle	Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
pubmed:affiliation	Department of Medical Oncology, Interbalkan Medical Center, Thessaloniki, Greece. georgsec@med.uoc.gr <georgsec@med.uoc.gr>
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II